Research graph
References from Trends and disparities in herpes zoster vaccination coverage among US adults with cardiovascular disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)
2008 · External reference
Increased myocardial infarction risk following herpes zoster infection
10.1093/ofid/ofad137 · 2023 · External reference
Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review
10.3390/jcm8040547 · 2019 · External reference
Herpes zoster and long-term risk of cardiovascular disease
10.1161/jaha.122.027451 · 2022 · External reference
Increased stroke risk following herpes zoster infection and protection with zoster vaccine
10.1093/cid/ciac549 · 2023 · External reference
Reciprocal relationship between herpes zoster and cardiovascular diseases: A nationwide population-based case-control study in Korea
10.1111/1346-8138.14597 · 2018 · External reference
Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data
10.1016/j.vaccine.2023.04.067 · 2023 · External reference
Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines
10.15585/mmwr.mm6703a5 · 2018 · External reference
Shingles vaccination among adults aged 60 and over: United States, 2018
2020 · External reference
Racial/ethnic and socioeconomic disparities in adult vaccination coverage
10.1016/j.amepre.2021.03.023 · 2021 · External reference
Unresolved reference
External reference
Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults (from the National Health Interview Survey, 2012)
10.1016/j.amjcard.2015.01.014 · 2015 · External reference
National health surveys and the behavioral model of health services use
10.1097/mlr.0b013e31817a835d · 2008 · External reference
Joinpoint regression methods of aggregate outcomes for complex survey data
10.1093/jssam/smac014 · 2022 · External reference
Unresolved reference
External reference
National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022
10.1016/j.ajic.2024.08.010 · 2025 · External reference
Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years
2011 · External reference
Pharmacy-based immunization delivery: A comprehensive history and current challenges
10.1002/jac5.70219 · 2026 · External reference
Associations between insurance-related affordable care act policy changes with HPV vaccine completion
10.1186/s12889-021-10328-4 · 2021 · External reference
Unresolved reference
External reference
The US Federal Retail Pharmacy Program: Optimizing COVID-19 vaccine delivery through a strategic public-private partnership
10.1177/00333549231186606 · 2023 · External reference
Disparities in influenza vaccination coverage and associated factors among adults with cardiovascular disease, United States, 2011-2020
10.5888/pcd19.220154 · 2022 · External reference
Health care utilization and the associated costs attributable to cardiovascular disease in Ireland: a cross-sectional study
10.1093/ehjqcco/qcae014 · 2025 · External reference
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis
10.1016/j.japh.2022.06.008 · 2022 · External reference
Risk factors for herpes zoster infection: A meta-analysis
10.1093/ofid/ofaa005 · 2020 · External reference
Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysis
10.1016/j.japh.2021.11.010 · 2022 · External reference
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications
10.1016/j.eclinm.2025.103241 · 2025 · External reference
Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting
10.7326/m23-2023 · 2024 · External reference
Herpes zoster vaccine effectiveness against cardiovascular events - a systematic literature review and meta-analysis
10.1093/eurheartj/ehaf784.3633 · 2025 · External reference
Aging of the immune system. Mechanisms and therapeutic targets
10.1513/annalsats.201602-095aw · 2016 · External reference
Gender differences in utilization of preventive care services in the United States
10.1089/jwh.2011.2876 · 2012 · External reference
A review of the relationship between socioeconomic status change and health
10.3390/ijerph20136249 · 2023 · External reference
An analysis of language as a barrier to receiving influenza vaccinations among an elderly Hispanic population in the United States
10.4061/2011/298787 · 2011 · External reference
Disaggregating ethnoracial disparities in physician trust
10.1016/j.ssresearch.2015.06.020 · 2015 · External reference
Primary care physicians who treat blacks and whites
10.1056/nejmsa040609 · 2004 · External reference
Strategies used by community-based organizations to expand access to seasonal vaccinations for Native American, Asian American, Black, and Latinx Populations
2026 · External reference
Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review
10.1016/j.diabres.2019.107983 · 2020 · External reference
Shingles vaccination in Medicare Part D and commercial enrollees after the Inflation Reduction Act
10.1016/j.vaccine.2025.127545 · 2025 · External reference
Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?
10.1016/j.vaccine.2013.06.041 · 2013 · External reference
Unresolved reference
External reference
